The key output of their collaborative research was the finding that the activation of PI3K-AKT pathway can lead to the growth of liver cancer or colorectal cancer cells 20, as well as the proliferation of hepatocellular carcinoma (HCC) cells 21. The gene discussed is AKT1; the disease is liver cancer.